Oncobiologics, Inc. Series B Warrant
ONSIZ
ONSIZ was delisted on the 16th of May, 2018.
0 hedge funds and large institutions have $0 invested in Oncobiologics, Inc. Series B Warrant in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $43K → $0 (-$43K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$18K |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$12K |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$6K |
| 4 |
PC
PointState Capital
New York
|
-$4K |
| 5 |
Millennium Management
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| – | -$18K | -416,666 | Closed |
|
|
ACA
2
Avoro Capital Advisors
New York
| – | -$12K | -233,333 | Closed |
|
|
MWNA
3
Marshall Wace North America
New York
| – | -$6K | -125,100 | Closed |
|
|
PC
4
PointState Capital
New York
| – | -$4K | -100,000 | Closed |
|
|
5
Millennium Management
New York
| – | -$1K | -29,658 | Closed |
|
|
MIM
6
Monashee Investment Management
Boston,
Massachusetts
| – | -$1K | -25,000 | Closed |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1K | -15,603 | Closed |
|
ONSIZ Hedge Fund Activity: Q2 2018 in Review
0 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series B Warrant (ONSIZ) for Q2 2018, worth a combined $0 — down 100% from $43K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ONSIZ and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Cormorant Asset Management, exiting entirely with an estimated $18K sold.
- 0 institutional investors held Oncobiologics, Inc. Series B Warrant (ONSIZ) as of Q2 2018, down from 9 in Q1 2018.
- Funds reported $0 of Oncobiologics, Inc. Series B Warrant stock for Q2 2018, down 100% quarter-over-quarter.
- 0 funds opened new Oncobiologics, Inc. Series B Warrant positions in Q2 2018 and 9 closed out, a net change of -9 holders.
- The largest Oncobiologics, Inc. Series B Warrant seller in Q2 2018 was Cormorant Asset Management, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2018.